Robeco Institutional Asset Management B.V.
Position in NBIX — Neurocrine Biosciences Inc
CIK 1418773
ROTTERDAM, P7
Position in NBIX
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$18,198,275
+$6,602,916 QoQ
Shares Held
107,976
+22.7% QoQ
Ownership
0.106%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#116
of 768 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 51%
Shared 0%
None 49%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Robeco Institutional Asset Management B.V. holds $403,524,623 across 13 Drug Manufacturers - Specialty & Generic names. NBIX ranks #4 (4.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RDY |
Dr Reddys Laboratories Ltd
|
18,021,100 | $261,125,739 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
123,056 | $66,675,432 | |
| 3 | VTRS |
Viatris Inc
|
2,080,468 | $33,037,831 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
This page
|
107,976 | $18,198,275 | |
| 5 | INDV |
Indivior Pharmaceuticals, Inc.
|
128,116 | $5,256,599 | |
| 6 | ALKS |
Alkermes plc.
|
92,592 | $4,851,357 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
174,003 | $4,282,213 | |
| 8 | PCRX |
Pacira BioSciences, Inc.
|
164,014 | $4,161,035 |
All Filings in NBIX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,198,275 | 107,976 | Shares | Defined | 2026-07-21 | |
| 2026-03-31 | $11,595,359 | 88,017 | Shares | Defined | 2026-04-21 | |
| 2025-12-31 | $16,063,807 | 113,261 | Shares | Defined | 2026-01-23 | |
| 2025-09-30 | $3,956,610 | 28,185 | Shares | Defined | 2025-10-22 | |
| 2025-06-30 | $1,897,667 | 15,098 | Shares | Defined | 2025-07-18 | |
| 2025-03-31 | $1,793,932 | 16,220 | Shares | Defined | 2025-04-23 | |
| 2024-12-31 | $1,997,541 | 14,634 | Shares | Defined | 2025-01-23 | |
| 2024-09-30 | $44,622,632 | 387,282 | Shares | Defined | 2024-10-29 | |
| 2024-06-30 | $45,979,164 | 333,981 | Shares | Defined | 2024-07-23 | |
| 2024-03-31 | $42,786,232 | 310,225 | Shares | Defined | 2024-04-24 | |
| 2023-12-31 | $23,413,620 | 177,699 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $17,332,537 | 154,067 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $14,631,870 | 155,163 | Shares | Defined | 2023-07-24 | |
| 2023-03-31 | $16,442,075 | 162,439 | Shares | Defined | 2023-05-04 | |
| 2022-12-31 | $22,479,085 | 188,204 | Shares | Defined | 2023-02-07 | |
| 2022-09-30 | $6,837,587 | 64,378 | Shares | Defined | 2022-12-01 | |
| 2022-06-30 | $860,748 | 8,830 | Shares | Defined | 2022-12-01 | |
| 2022-03-31 | $57,187 | 610 | Shares | Defined | 2022-12-01 | |
| 2021-12-31 | $293,666 | 3,448 | Shares | Defined | 2022-12-01 | |
| 2021-09-30 | $324,367 | 3,382 | Shares | Defined | 2022-12-01 | |
| 2021-06-30 | $329,136 | 3,382 | Shares | Defined | 2022-12-01 | |
| 2021-03-31 | $328,899 | 3,382 | Shares | Defined | 2022-12-01 | |
| 2020-12-31 | $392,122 | 4,091 | Shares | Defined | 2022-12-01 | |
| 2020-09-30 | $393,390 | 4,091 | Shares | Defined | 2021-01-19 | |
| 2020-06-30 | $15,494 | 127 | Shares | Defined | 2021-01-19 | |
| 2020-03-31 | $290,461 | 3,356 | Shares | Defined | 2021-01-19 | |
| No filing history on record for this holder in this stock. | ||||||